RGNX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.79%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,213,884.00

REGENXBIO Insider Trading History Chart

REGENXBIO Share Price & Price History

^$9.02

▼ -0.111 (-1.22%)

As of 04/29/2025 10:51 AM ET

Days: 30 | 90 | 365

REGENXBIO Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/1/2024	Argeris N Karabelas	Director	Sell	10,000	$10.11	$101,100.00	11,286
9/3/2024	Argeris N Karabelas	Director	Sell	10,000	$11.56	$115,600.00	11,286
8/1/2024	Argeris N Karabelas	Director	Sell	10,100	$13.51	$136,451.00	11,286
8/1/2024	Curran Simpson	CEO	Sell	100	$15.00	$1,500.00	170,037
7/29/2024	Argeris N Karabelas	Director	Sell	11,000	$15.04	$165,440.00	11,286
7/29/2024	Curran Simpson	CEO	Sell	9,648	$15.04	$145,105.92	170,137
7/24/2024	Kenneth T Mills	Director	Sell	12,221	$13.78	$168,405.38	408,035
7/17/2024	Kenneth T Mills	Director	Sell	2,210	$13.77	$30,431.70	408,035
7/1/2024	Argeris N Karabelas	Director	Sell	10,000	$11.27	$112,700.00	11,286
5/14/2024	Kenneth T Mills	CEO	Sell	15,000	$15.81	$237,150.00	408,035
4/15/2024	Kenneth T Mills	CEO	Sell	15,000	$18.19	$272,850.00	408,035
3/14/2024	Kenneth T Mills	CEO	Sell	15,000	$21.86	$327,900.00	408,035
3/5/2024	Steve Pakola	Insider	Sell	12,878	$28.36	$365,220.08	107,192
2/14/2024	Kenneth T Mills	CEO	Sell	15,000	$16.76	$251,400.00	408,035
1/16/2024	Kenneth T Mills	CEO	Sell	45,000	$15.18	$683,100.00	408,035
1/3/2024	Steve Pakola	Insider	Sell	17,237	$17.39	$299,751.43	107,192
12/19/2023	Kenneth T Mills	CEO	Sell	45,000	$19.68	$885,600.00	355,289
8/30/2022	Vittal Vasista	CFO	Sell	2,400	$30.24	$72,576.00	135,160
8/1/2022	Vittal Vasista	CFO	Sell	2,400	$31.25	$75,000.00	155,240
7/13/2022	Vittal Vasista	CFO	Sell	4,332	$30.01	$130,003.32	158,108

See Full Table

SEC Filings (Institutional Ownership Changes) for REGENXBIO (NASDAQ:RGNX)

88.08% of REGENXBIO stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

REGENXBIO Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	FNY Investment Advisers LLC	5,000	$35K	0.0%	N/A	0.010%
4/17/2025	Janney Montgomery Scott LLC	67,752	$0.48M	0.0%	N/A	0.135%
4/16/2025	Wealth Enhancement Advisory Services LLC	17,172	$0.12M	0.0%	N/A	0.034%
4/15/2025	Assenagon Asset Management S.A.	573,173	$4.10M	0.0%	-33.1%	1.144%
4/14/2025	Pallas Capital Advisors LLC	10,415	$74K	0.0%	N/A	0.021%
4/10/2025	Hennion & Walsh Asset Management Inc.	159,383	$1.14M	0.1%	-3.2%	0.318%
4/8/2025	Rhumbline Advisers	71,155	$0.51M	0.0%	-4.2%	0.142%
4/7/2025	GAMMA Investing LLC	16,188	$0.12M	0.0%	+372.1%	0.032%
2/18/2025	Alpine Global Management LLC	22,687	$0.18M	0.0%	N/A	0.046%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	72,183	$0.56M	0.0%	+9.2%	0.146%
2/17/2025	Squarepoint Ops LLC	37,230	$0.29M	0.0%	-6.2%	0.075%
2/17/2025	Two Sigma Advisers LP	180,000	$1.39M	0.0%	+164.7%	0.363%
2/17/2025	Two Sigma Investments LP	389,428	$3.01M	0.0%	+209.2%	0.786%
2/17/2025	Sherbrooke Park Advisers LLC	24,330	$0.19M	0.1%	-18.1%	0.049%
2/17/2025	Rafferty Asset Management LLC	93,821	$0.73M	0.0%	+22.4%	0.189%
2/17/2025	Redmile Group LLC	4,794,780	$37.06M	2.6%	-2.0%	9.679%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	57,841	$0.45M	0.1%	N/A	0.117%
2/17/2025	ProShare Advisors LLC	15,314	$0.12M	0.0%	+22.4%	0.031%
2/17/2025	Millennium Management LLC	1,322,344	$10.22M	0.0%	+406.3%	2.669%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	100,452	$0.78M	0.0%	+2.9%	0.203%
2/17/2025	Laurion Capital Management LP	10,188	$79K	0.0%	N/A	0.021%
2/17/2025	Integral Health Asset Management LLC	900,000	$6.96M	0.6%	-29.4%	1.817%
2/17/2025	Hudson Bay Capital Management LP	308,100	$2.38M	0.0%	+43.3%	0.622%
2/17/2025	Graham Capital Management L.P.	28,542	$0.22M	0.0%	+59.8%	0.058%
2/17/2025	D. E. Shaw & Co. Inc.	63,377	$0.49M	0.0%	+15.0%	0.128%
2/17/2025	Deutsche Bank AG	200,375	$1.55M	0.0%	+8.5%	0.404%
2/17/2025	Corton Capital Inc.	13,276	$0.10M	0.1%	N/A	0.027%
2/17/2025	Cubist Systematic Strategies LLC	361,313	$2.79M	0.0%	N/A	0.729%
2/17/2025	Brevan Howard Capital Management LP	41,160	$0.32M	0.0%	N/A	0.083%
2/17/2025	Balyasny Asset Management L.P.	1,187,102	$9.18M	0.0%	+6.0%	2.396%
2/17/2025	Bank of America Corp DE	281,204	$2.17M	0.0%	-37.0%	0.568%
2/17/2025	BNP Paribas Financial Markets	96,093	$0.74M	0.0%	+370.1%	0.194%
2/17/2025	Ameriprise Financial Inc.	284,521	$2.20M	0.0%	+4.7%	0.574%
2/14/2025	Jane Street Group LLC	164,911	$1.28M	0.0%	+325.3%	0.333%
2/14/2025	PDT Partners LLC	63,015	$0.49M	0.0%	N/A	0.127%
2/14/2025	Northern Trust Corp	465,261	$3.60M	0.0%	-4.7%	0.939%
2/14/2025	Voya Investment Management LLC	43,502	$0.34M	0.0%	+7.5%	0.088%
2/14/2025	Adage Capital Partners GP L.L.C.	500,000	$3.87M	0.0%	N/A	1.009%
2/14/2025	Price T Rowe Associates Inc. MD	23,910	$0.19M	0.0%	+9.0%	0.048%
2/14/2025	Quantessence Capital LLC	34,888	$0.27M	0.1%	N/A	0.070%
2/14/2025	Alpine Global Management LLC	22,687	$0.18M	0.0%	N/A	0.046%
2/14/2025	Hsbc Holdings PLC	84,817	$0.63M	0.0%	+132.3%	0.171%
2/14/2025	Stifel Financial Corp	188,844	$1.46M	0.0%	+26.5%	0.381%
2/14/2025	State of Tennessee Department of Treasury	10,869	$84K	0.0%	-43.8%	0.022%
2/14/2025	Voss Capital LP	332,814	$2.57M	0.2%	N/A	0.672%
2/14/2025	Tower Research Capital LLC TRC	13,138	$0.10M	0.0%	+442.0%	0.027%
2/14/2025	Dimensional Fund Advisors LP	1,171,422	$9.05M	0.0%	+1.8%	2.365%
2/13/2025	CANADA LIFE ASSURANCE Co	6,649	$51K	0.0%	-84.7%	0.013%
2/13/2025	Jump Financial LLC	192,708	$1.49M	0.0%	+144.9%	0.389%
2/13/2025	Walleye Capital LLC	88,148	$0.68M	0.0%	N/A	0.178%
2/13/2025	XTX Topco Ltd	108,120	$0.84M	0.1%	+720.5%	0.218%
2/13/2025	Barclays PLC	127,065	$0.98M	0.0%	+9.5%	0.256%
2/13/2025	Rockefeller Capital Management L.P.	27,108	$0.21M	0.0%	-33.8%	0.055%
2/13/2025	Raymond James Financial Inc.	73,510	$0.57M	0.0%	N/A	0.148%
2/13/2025	Renaissance Technologies LLC	271,300	$2.10M	0.0%	N/A	0.548%
2/13/2025	Legal & General Group Plc	44,823	$0.35M	0.0%	-63.1%	0.090%
2/13/2025	Invesco Ltd.	52,128	$0.40M	0.0%	-61.7%	0.105%
2/13/2025	ArchPoint Investors	221,528	$1.71M	0.6%	-1.2%	0.447%
2/13/2025	Aristides Capital LLC	24,200	$0.19M	0.0%	N/A	0.049%
2/13/2025	Dynamic Technology Lab Private Ltd	10,159	$79K	0.0%	N/A	0.021%
2/13/2025	Wells Fargo & Company MN	48,437	$0.37M	0.0%	+34.0%	0.098%
2/12/2025	ExodusPoint Capital Management LP	105,668	$0.82M	0.0%	-44.1%	0.213%
2/12/2025	Trexquant Investment LP	150,022	$1.16M	0.0%	N/A	0.303%
2/12/2025	Geode Capital Management LLC	1,094,225	$8.46M	0.0%	+0.5%	2.209%
2/12/2025	Alliancebernstein L.P.	53,900	$0.42M	0.0%	-8.7%	0.109%
2/12/2025	DnB Asset Management AS	14,539	$0.11M	0.0%	+20.1%	0.029%
2/12/2025	Norges Bank	449,400	$3.47M	0.0%	N/A	0.907%
2/12/2025	BIT Capital GmbH	29,696	$0.23M	0.0%	N/A	0.060%
2/12/2025	JPMorgan Chase & Co.	4,136,517	$31.98M	0.0%	+67.0%	8.350%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	25,430	$0.20M	0.0%	+48.2%	0.051%
2/11/2025	EntryPoint Capital LLC	12,538	$97K	0.0%	N/A	0.025%
2/11/2025	Corebridge Financial Inc.	22,889	$0.18M	0.0%	-13.3%	0.046%
2/11/2025	Vanguard Group Inc.	2,985,952	$23.08M	0.0%	-31.7%	6.027%
2/11/2025	Napatree Capital LLC	33,525	$0.26M	0.2%	-4.6%	0.068%
2/11/2025	KLP Kapitalforvaltning AS	7,000	$54K	0.0%	N/A	0.014%
2/11/2025	AXQ Capital LP	13,732	$0.11M	0.0%	N/A	0.028%
2/11/2025	American Century Companies Inc.	95,026	$0.74M	0.0%	+8.8%	0.192%
2/11/2025	Teacher Retirement System of Texas	12,590	$97K	0.0%	+19.9%	0.025%
2/7/2025	AlphaQuest LLC	7,959	$62K	0.0%	-66.9%	0.016%
2/6/2025	Raymond James Financial Inc.	73,510	$0.57M	0.0%	N/A	0.148%
2/6/2025	Charles Schwab Investment Management Inc.	349,730	$2.70M	0.0%	-16.3%	0.706%
2/4/2025	Bank of New York Mellon Corp	161,136	$1.25M	0.0%	-49.7%	0.325%
2/4/2025	Y Intercept Hong Kong Ltd	137,402	$1.06M	0.1%	N/A	0.277%
1/31/2025	New York State Common Retirement Fund	13,746	$0.11M	0.0%	-17.4%	0.028%
1/30/2025	Rhumbline Advisers	74,269	$0.57M	0.0%	-35.4%	0.150%
1/17/2025	SG Americas Securities LLC	10,375	$80K	0.0%	-25.6%	0.021%
1/15/2025	Hennion & Walsh Asset Management Inc.	164,729	$1.27M	0.1%	+8.6%	0.332%
1/14/2025	Assenagon Asset Management S.A.	856,572	$6.62M	0.0%	+53.0%	1.729%
1/10/2025	Harbor Capital Advisors Inc.	25,607	$0.20M	0.0%	-29.0%	0.052%
1/3/2025	GAMMA Investing LLC	3,429	$27K	0.0%	+273.1%	0.007%
12/26/2024	JPMorgan Chase & Co.	2,477,311	$25.99M	0.0%	-17.8%	5.000%
12/19/2024	Principal Financial Group Inc.	214,353	$2.25M	0.0%	-4.9%	0.433%
11/19/2024	Barclays PLC	116,024	$1.22M	0.0%	+141.3%	0.234%
11/16/2024	Geode Capital Management LLC	1,088,651	$11.42M	0.0%	+4.2%	2.198%
11/15/2024	Barclays PLC	116,024	$1.22M	0.0%	+141.3%	0.234%
11/15/2024	XTX Topco Ltd	13,177	$0.14M	0.0%	-75.0%	0.027%
11/15/2024	National Bank of Canada FI	68,000	$0.71M	0.0%	N/A	0.137%
11/15/2024	Jane Street Group LLC	38,776	$0.41M	0.0%	-48.1%	0.078%
11/15/2024	State Street Corp	2,782,883	$29.19M	0.0%	-3.1%	5.617%
11/15/2024	Stifel Financial Corp	149,280	$1.57M	0.0%	+13.3%	0.301%

Data available starting January 2016

See Full Table

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase I/II clinical trial for the treatment of Duchenne muscular dystrophy. It also develops RGX-121 for the treatment of mucopolysaccharidosis type II that is in Phase III clinical trial; RGX-111 for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late infantile neuronal ceroid lipofuscinosis type II; and RGX-381 to treat the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.

Today's Range

Now: $9.02

$8.85

50 Day Range

MA: $6.94

$5.31

$9.20

52 Week Range

Now: $9.02

$5.04

$17.52

Volume

497 shs

Average Volume

813,367 shs

Market Capitalization

$452.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Who are the company insiders with the largest holdings of REGENXBIO?: REGENXBIO's top insider shareholders include:
Kenneth T Mills (CEO)
Kenneth T Mills (Director)
Curran Simpson (CEO)
Steve Pakola (Insider)
Argeris N Karabelas (Director)
Learn More about top insider investors at REGENXBIO.
Who are the major institutional investors of REGENXBIO?: REGENXBIO's top institutional investors include:
Assenagon Asset Management S.A. — 1.14%
Hennion & Walsh Asset Management Inc. — 0.32%
Rhumbline Advisers — 0.14%
Janney Montgomery Scott LLC — 0.14%
Wealth Enhancement Advisory Services LLC — 0.03%
GAMMA Investing LLC — 0.03%
Learn More about top institutional investors of REGENXBIO stock.
Which institutional investors are selling REGENXBIO stock?: In the previous quarter, RGNX stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Hennion & Walsh Asset Management Inc.
Rhumbline Advisers
In the previous year, company insiders that have sold REGENXBIO company stock include:
Kenneth T Mills (CEO)
Kenneth T Mills (Director)
Curran Simpson (CEO)
Steve Pakola (Insider)
Learn More investors selling REGENXBIO stock.
Which institutional investors are buying REGENXBIO stock?: Within the previous quarter, RGNX stock was bought by institutional investors including:
Janney Montgomery Scott LLC
Wealth Enhancement Advisory Services LLC
GAMMA Investing LLC
Pallas Capital Advisors LLC
FNY Investment Advisers LLC